JP2022530168A5 - - Google Patents

Info

Publication number
JP2022530168A5
JP2022530168A5 JP2021564417A JP2021564417A JP2022530168A5 JP 2022530168 A5 JP2022530168 A5 JP 2022530168A5 JP 2021564417 A JP2021564417 A JP 2021564417A JP 2021564417 A JP2021564417 A JP 2021564417A JP 2022530168 A5 JP2022530168 A5 JP 2022530168A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
vector
protein
composition according
myocardial infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021564417A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530168A (ja
JP7707075B2 (ja
Filing date
Publication date
Priority claimed from GBGB1906052.4A external-priority patent/GB201906052D0/en
Application filed filed Critical
Publication of JP2022530168A publication Critical patent/JP2022530168A/ja
Publication of JP2022530168A5 publication Critical patent/JP2022530168A5/ja
Priority to JP2025029903A priority Critical patent/JP2025107171A/ja
Application granted granted Critical
Publication of JP7707075B2 publication Critical patent/JP7707075B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021564417A 2019-04-30 2020-04-30 心臓保護的活性のあるタンパク質 Active JP7707075B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025029903A JP2025107171A (ja) 2019-04-30 2025-02-27 心臓保護的活性のあるタンパク質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1906052.4A GB201906052D0 (en) 2019-04-30 2019-04-30 Proteins with cardioprotective activity
GB1906052.4 2019-04-30
PCT/EP2020/062156 WO2020221906A1 (en) 2019-04-30 2020-04-30 Proteins with cardioprotective activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025029903A Division JP2025107171A (ja) 2019-04-30 2025-02-27 心臓保護的活性のあるタンパク質

Publications (3)

Publication Number Publication Date
JP2022530168A JP2022530168A (ja) 2022-06-27
JP2022530168A5 true JP2022530168A5 (cg-RX-API-DMAC7.html) 2023-05-12
JP7707075B2 JP7707075B2 (ja) 2025-07-14

Family

ID=66589570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021564417A Active JP7707075B2 (ja) 2019-04-30 2020-04-30 心臓保護的活性のあるタンパク質
JP2025029903A Pending JP2025107171A (ja) 2019-04-30 2025-02-27 心臓保護的活性のあるタンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025029903A Pending JP2025107171A (ja) 2019-04-30 2025-02-27 心臓保護的活性のあるタンパク質

Country Status (25)

Country Link
US (3) US12569574B2 (cg-RX-API-DMAC7.html)
EP (2) EP3962534B1 (cg-RX-API-DMAC7.html)
JP (2) JP7707075B2 (cg-RX-API-DMAC7.html)
KR (2) KR20220027829A (cg-RX-API-DMAC7.html)
CN (2) CN120518738A (cg-RX-API-DMAC7.html)
AU (1) AU2020267029A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021021626A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137662A1 (cg-RX-API-DMAC7.html)
DK (1) DK3962534T3 (cg-RX-API-DMAC7.html)
ES (1) ES2975422T3 (cg-RX-API-DMAC7.html)
FI (1) FI3962534T3 (cg-RX-API-DMAC7.html)
GB (1) GB201906052D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20240441T1 (cg-RX-API-DMAC7.html)
HU (1) HUE066324T2 (cg-RX-API-DMAC7.html)
IL (1) IL287525A (cg-RX-API-DMAC7.html)
LT (1) LT3962534T (cg-RX-API-DMAC7.html)
MX (2) MX2021013298A (cg-RX-API-DMAC7.html)
PL (1) PL3962534T3 (cg-RX-API-DMAC7.html)
PT (1) PT3962534T (cg-RX-API-DMAC7.html)
RS (1) RS65469B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202111267WA (cg-RX-API-DMAC7.html)
SI (1) SI3962534T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400151T1 (cg-RX-API-DMAC7.html)
WO (1) WO2020221906A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA202107778B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201906052D0 (en) 2019-04-30 2019-06-12 Int Centre For Genetic Engineering And Biotechnology Proteins with cardioprotective activity
WO2025253097A1 (en) * 2024-06-03 2025-12-11 Forcefield Therapeutics Limited Proteins with cardiopreservation activity
GB202415505D0 (en) * 2024-10-21 2024-12-04 King S College London Lipid nanoparticles for cardiac protection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2416538A1 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2003265867A1 (en) * 2002-08-29 2004-10-18 Oxford Glycosciences (Uk) Ltd. A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
US7312079B1 (en) * 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
DK2623605T3 (en) 2007-04-09 2019-03-25 Univ Florida RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
US20130136738A1 (en) * 2010-01-26 2013-05-30 Zhaodan Cao Methods of Treating Glucose Metabolism Disorders
EP2533796A4 (en) * 2010-02-12 2013-12-04 Ngm Biopharmaceuticals Inc METHOD FOR THE TREATMENT OF GLUCOSE TISSUE CHANGES
KR102248900B1 (ko) 2011-09-30 2021-05-07 소마로직, 인크. 심혈관 위험 사건 예측 및 그것의 용도
ITRM20110685A1 (it) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
EP2981334A4 (en) * 2013-04-03 2016-11-23 Univ California COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY
US20170209621A1 (en) * 2016-01-21 2017-07-27 The Board Of Trustees Of The Leland Stanford Junior University Use of chordin-like 1 or collagen vi with mesenchymal stem cells
KR102022021B1 (ko) * 2018-01-10 2019-09-18 한국과학기술연구원 심혈관 질환의 진단을 위한 바이오마커 및 이의 용도
GB201906052D0 (en) 2019-04-30 2019-06-12 Int Centre For Genetic Engineering And Biotechnology Proteins with cardioprotective activity

Similar Documents

Publication Publication Date Title
JP2021534809A (ja) Aavカプシドの向性の再指向化
JP2020508685A5 (cg-RX-API-DMAC7.html)
JP2020203926A5 (cg-RX-API-DMAC7.html)
JP2024511163A5 (cg-RX-API-DMAC7.html)
JP2020203894A5 (cg-RX-API-DMAC7.html)
JP2025107171A5 (cg-RX-API-DMAC7.html)
JP2021515548A5 (cg-RX-API-DMAC7.html)
JP2020510424A5 (cg-RX-API-DMAC7.html)
IL319481A (en) Variants of acid alpha-glucosidase and their uses
JP2016538885A5 (cg-RX-API-DMAC7.html)
JP2009525757A5 (cg-RX-API-DMAC7.html)
JP2022520232A5 (cg-RX-API-DMAC7.html)
WO2000029024A9 (en) Formulation of adenovirus for gene therapy
JP2019536425A5 (cg-RX-API-DMAC7.html)
JP2022530824A5 (cg-RX-API-DMAC7.html)
CN121889499A (zh) 用于治疗α1-抗胰蛋白酶缺乏症的方法和组合物
JP2018515101A5 (cg-RX-API-DMAC7.html)
JP2024503091A5 (cg-RX-API-DMAC7.html)
JP2021518159A5 (cg-RX-API-DMAC7.html)
JP2023522154A5 (cg-RX-API-DMAC7.html)
JP2025513066A5 (cg-RX-API-DMAC7.html)
FI3962534T3 (fi) Proteiineja, joilla on kardioprotektiivinen vaikutus
Wodnar-Filipowicz et al. Cloning and sequence analysis of cDNA for rat spleen thymosin beta 4.
JP2025516583A5 (cg-RX-API-DMAC7.html)
IL298772A (en) Coding-optimized nucleic acid encoding the SMN1 protein and its use